The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
The BTK inhibitor ibrutinib may protect against pulmonary injury in COVID-19–infected patients
Open accessAbstract
Treon et al provide early clinical data supporting a theoretical rationale for continuing ibrutinib in patients receiving the drug during COVID-19 illness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Wu, C., Chen, X., Cai, Y., Xia, J., Zhou, X., Xu, S., Huang, H., Zhang, L., Zhou, X., Du, C., et al. (2020) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2020.0994 · Cited by 8,249
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Covid-19 in Critically Ill Patients in the Seattle Region — Case Series
Bhatraju, P. K., Ghassemieh, B. J., Nichols, M., Kim, R., Jerome, K. R., Nalla, A. K., Greninger, A. L., Pipavath, S., Wurfel, M. M., Evans, L., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2004500 · Cited by 2,583
[A pathological report of three COVID-19 cases by minimal invasive autopsies].
Yao, X. H., Li, T. Y., He, Z. C., Ping, Y. F., Liu, H. W., Yu, S. C., Mou, H. M., Wang, L. H., Zhang, H. R., Fu, W. J., et al. (2020) · PubMed · doi:10.3760/cma.j.cn112151-20200312-00193 · Cited by 963
Ibrutinib for chronic graft-versus-host disease after failure of prior therapy
Miklos, D., Cutler, C. S., Arora, M., Waller, E. K., Jagasia, M., Pusic, I., Flowers, M. E., Logan, A. C., Nakamura, R., Blazar, B. R., et al. (2017) · Blood · doi:10.1182/blood-2017-07-793786 · Cited by 514
He, L., Ding, Y., Zhang, Q., Che, X., He, Y., Shen, H., Wang, H., Li, Z., Zhao, L., Geng, J., et al. (2006) · The Journal of Pathology · doi:10.1002/path.2067 · Cited by 366
Yang, G., Zhou, Y., Liu, X., Xu, L., Cao, Y., Manning, R. J., Patterson, C. J., Buhrlage, S. J., Gray, N., Tai, Y.-T., et al. (2013) · Blood · doi:10.1182/blood-2012-12-475111 · Cited by 352
Self-citationCharacterization of Cytokine/Chemokine Profiles of Severe Acute Respiratory Syndrome
Jiang, Y., Xu, J., Zhou, C., Wu, Z., Zhong, S., Liu, J., Luo, W., Chen, T., Qin, Q., & Deng, P. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200407-857oc · Cited by 323
Jefferies, C. A., Doyle, S., Brunner, C., Dunne, A., Brint, E., Wietek, C., Walch, E., Wirth, T., & O'Neill, L. A. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301484200 · Cited by 292
Ley, K. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701135 · Cited by 259
Niemann, C. U., Herman, S. E. M., Maric, I., Gomez-Rodriguez, J., Biancotto, A., Chang, B. Y., Martyr, S., Stetler-Stevenson, M., Yuan, C. M., Calvo, K. R., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1965 · Cited by 201
HCK is a survival determinant transactivated by mutated MYD88, and a direct target of ibrutinib
Yang, G., Buhrlage, S. J., Tan, L., Liu, X., Chen, J., Xu, L., Tsakmaklis, N., Chen, J. G., Patterson, C. J., Brown, J. R., et al. (2016) · Blood · doi:10.1182/blood-2016-01-695098 · Cited by 135
Self-citationErnst, M., Inglese, M., Scholz, G. M., Harder, K. W., Clay, F. J., Bozinovski, S., Waring, P. M., Darwiche, R., Kay, T., Sly, P. D., et al. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20020873 · Cited by 131
Chuquimia, O. D., Petursdottír, D. H., Períolo, N., & Fernández, C. (2012) · Infection and Immunity · doi:10.1128/iai.00950-12 · Cited by 126
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia
Fiorcari, S., Maffei, R., Audrito, V., Martinelli, S., ten Hacken, E., Zucchini, P., Grisendi, G., Potenza, L., Luppi, M., Burger, J. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11782 · Cited by 108
Wang, Y., & Liu, L. (2016) · mBio · doi:10.1128/mbio.01872-15 · Cited by 95
Thorley, A. J., Grandolfo, D., Lim, E. K. S., Goldstraw, P. G., Young, A., & Tetley, T. D. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021827 · Cited by 94
Inhibiting Bruton’s tyrosine kinase rescues mice from lethal influenza-induced acute lung injury
Florence, J., Krupa, A., Booshehri, L. M., Davis, S. A., Matthay, M. A., & Kurdowska, A. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00047.2018 · Cited by 91
Chen, J. G., Liu, X., Munshi, M., Xu, L., Tsakmaklis, N., Demos, M. G., Kofides, A., Guerrera, M. L., Chan, G. G., Patterson, C. J., et al. (2018) · Blood · doi:10.1182/blood-2017-10-811752 · Cited by 88
Self-citationPechkovsky, D. V., Goldmann, T., Ludwig, C., Prasse, A., Vollmer, E., Müller–Quernheim, J., & Zissel, G. (2005) · Respiratory Research · doi:10.1186/1465-9921-6-75 · Cited by 51
Vos, J. M. I., Tsakmaklis, N., Patterson, C. J., Meid, K., Castillo, J. J., Brodsky, P., Ganz, T., Pals, S. T., Kersten, M. J., Xu, L., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.172627 · Cited by 25
Self-citationGreil, R., Tedeschi, A., Moreno, C., Anz, B. M., Larratt, L. M., Šimkovič, M., Gill, D. S., Gribben, J. G., Flinn, I. W., Wang, Z., et al. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04536-6 · Cited by 22
Cited by
Vijenthira, A., Gong, I. Y., Fox, T. A., Booth, S., Cook, G., Fattizzo, B., Martín-Moro, F., Razanamahery, J., Riches, J. C., Zwicker, J., et al. (2020) · Blood · doi:10.1182/blood.2020008824 · Cited by 625
COVID-19 in Immunocompromised Hosts: What We Know So Far
Fung, M., & Babik, J. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa863 · Cited by 526
The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity
Osuchowski, M. F., Winkler, M. S., Skirecki, T., Cajander, S., Shankar-Hari, M., Lachmann, G., Monneret, G., Venet, F., Bauer, M., Brunkhorst, F. M., et al. (2021) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(21)00218-6 · Cited by 520
Immunopathology of Hyperinflammation in COVID-19
Gustine, J. N., & Jones, D. (2021) · The American Journal of Pathology · doi:10.1016/j.ajpath.2020.08.009 · Cited by 516
“initially reported a possible clinical benefit of ibrutinib in a case series of Waldenström macroglobulinemia patients infected with COVID-19.(98) Results from a pilot study (n=19) of another BTK inhibitor, acalabrutinib, were recently reported for severe patients hospitalized with COVID-19.”
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Metadata
- Authors
- Treon, S. P., Castillo, J. J., Skarbnik, A. P., Soumerai, J. D., Ghobrial, I. M., Guerrera, M. L., Meid, K., & Yang, G.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2020-05-21
- Volume
- 135
- Issue
- 21
- Pages
- 1912-1915
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W3016852213
- Cited by
- 909
- References
- 26
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.